Abiopharma

Ethan Allen Announces Release Date for its Fiscal 2026 Third Quarter Results

Assertio Holdings, Inc. - Assertio Announces Agreement to be Acquired by Garda Therapeutics

Assertio Announces Agreement to be Acquired by Garda Therapeutics

Forte Biosciences Inc - Forte Biosciences Announces Proposed Public Offering

Forte Biosciences Announces Proposed Public Offering

BELPOINTE OZ ISSUES CHAIRMAN & CEO LETTER TO UNITHOLDERS

Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

AGNC Investment Corp. Declares Monthly Common Stock Dividend of $0.12 per Common Share for April 2026

Stoke Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference

New Era Energy & Digital Closes Multi-Tranche $290 Million Senior Secured Term Loan Credit Facility with Macquarie Group to Finance Texas Critical Data Center Flagship Project